The healthcare landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a potential advance. Unlike subcutaneous injections, this approach offers a less invasive way to administer GLP-1 medications. These patches slowly release the drug through the surface offering a consistent dose of the therapeutic agent, which can… Read More